Navigation Links
Sihuan Pharmaceutical Announces 2011 Annual Results
Date:3/19/2012

HONG KONG, March 19, 2012 /PRNewswire-Asia/ -- Sihuan  Pharmaceutical Holdings Group Ltd. (HKEx: 0460) ("Sihuan Pharmaceutical" or the "Company"), a leading pharmaceutical company with the largest cardio-cerebral vascular drug franchise in China's prescription market, today announced its annual results for the year ended 31 December 2011. Despite a very challenging environment, Sihuan Pharmaceutical once again posted exceptional performance. The Company's product portfolio was further diversified with newly acquired products, demonstrating its strong sales and marketing capabilities and successful identification, acquisition, and integration of high potential assets. In addition, the Group's continuous efforts in research and development ("R&D") were reflected in breakthroughs by both its innovative and generic drugs.

Financial Highlights

  • Revenue of the Group increased by 116.2% to RMB2,242.1 million in 2011 from RMB1,036.9 million;
  • Gross profit margin improved from 71.8% in 2010 to 76.5% in 2011;
  • Profit attributable to owners of the Company increased by 57.8% to RMB824.0 million in 2011;
  • Basic earnings per share increased by approximately 22.0% in 2010 to approximately RMB15.90 cents; and
  • A final dividend of RMB2.5 cents per share and a second special dividend of RMB7.2 cents per share were recommended by the Board and are subject to the approval of the shareholders at the annual general meeting of the Company to be held on 1 June 2012.
  •  Results for the year ended 31 DecemberKey Income Statement ItemsRMB '000Change % 20112010 Revenue

    2,242,063

    1,036,881

    116.2%Gross profit

    1,714,464

    744,743

    130.2%Operating profit

    990,348

    613,313

    61.5%Profit attributable to owners of the Company

    824,048

    522,065

    57.8%Key Financial Ratios20112010 Gross profit margin
    '/>"/>

    SOURCE Sihuan Pharmaceutical Holdings Group Ltd.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5

    Related medicine technology :

    1. Sihuan Pharmaceutical Achieves Important R&D Breakthrough
    2. Branded Prescription Pharmaceutical Sales Outlook to 2016
    3. Pharmaceuticals: Global Industry Guide
    4. Avanir Pharmaceuticals Announces Appointment of Rohan Palekar as Chief Commercial Officer
    5. JacksonWhite Files Overtime Lawsuit Against Sunovion Pharmaceuticals
    6. Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2011 Financial Results and Reviews Recent Developments
    7. Pharmaceutical & Healthcare Annual Deals Analysis 2012
    8. Omnicell to Exhibit at Dubai International Pharmaceuticals and Technologies Conference and Exhibition
    9. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Wednesday, March 14
    10. Auxilium Pharmaceuticals to Present at the 2012 Barclays Capital Global Healthcare Conference
    11. S1 Pharmaceuticals Announces New Executive Management and Scientific Advisory Board Appointments
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/24/2014)... Mexico , Dec. 24, 2014  Novastem, ... of its first patient in its study for ... the American Stroke Association, ischemic strokes account for ... to enroll qualified patients in the study, entitled ... Administration of Allogeneic Mesenchymal Stem Cells and Intrathecal ...
    (Date:12/24/2014)... , Dec. 24, 2014 Kinex Pharmaceuticals announced ... KX2-361 at Roswell Park Cancer Institute. KX2-361 ... drug that has shown potent inhibitory activity against a ... that are resistant to Temozolomide (T98G), the most widely ... a well-established brain tumor mouse model, KX2-361 consistently clears ...
    (Date:12/24/2014)... Dec. 24, 2014  Diplomat Pharmacy, Inc. (NYSE: ... is proud to announce Jennifer Hagerman , Pharm.D., ... will take office as the president of the Michigan ... ceremony will take place Feb. 28, 2015, at the ... at the Renaissance Center in Detroit, Michigan ...
    Breaking Medicine Technology:Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 2Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 3Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 4Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 2Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 3Diplomat's senior director of education and quality to be inducted as 2015 president of the Michigan Pharmacists Association 2Diplomat's senior director of education and quality to be inducted as 2015 president of the Michigan Pharmacists Association 3
    ... Show Superior Decrease in Pain Scores Compared to Saline ... the results of a six-month safety and efficacy study ... decreasing the pain of knee osteoarthritis (OA) at 26 ... superior to saline in decreasing pain at 26 weeks ...
    ... Phase 3 Avanafil Study REVIVE (TA-301) is Complete MOUNTAIN ... VVUS ), a biopharmaceutical company developing innovative, next-generation ... sexual health, today announced that it has initiated an ... avanafil, in males with erectile dysfunction (ED). VIVUS ...
    Cached Medicine Technology:Ferring Pharmaceuticals Unveils Six-Month Efficacy Data for EUFLEXXA(R) for the Treatment of Osteoarthritis Knee Pain 2Ferring Pharmaceuticals Unveils Six-Month Efficacy Data for EUFLEXXA(R) for the Treatment of Osteoarthritis Knee Pain 3VIVUS Initiates Open Label Safety Study of Avanafil for Erectile Dysfunction 2VIVUS Initiates Open Label Safety Study of Avanafil for Erectile Dysfunction 3
    (Date:12/26/2014)... DW-InductionHeating.com (DaWei Induction Heating Co.) is a ... producing and marketing of a series of induction heating ... new series of induction brazing equipments . , ... induction brazing refers to the joining of two ... heat. The manager says that there are fundamental differences ...
    (Date:12/25/2014)... This is a professional and in-depth study ... with a focus on the Chinese market. The report ... Sterilizers manufacturers and is a valuable source of guidance ... industry. This report provides a basic overview of the ... this part, the report presents the company profile, product ...
    (Date:12/25/2014)... The report “TS-1 (Colorectal Cancer) – Forecast and ... landscape, unmet needs, current pipeline and commercial opportunities in ... which is typically used for treating colorectal cancer. It ... gastric cancer and pancreatic cancer. TS-1 is composed of ... approved in 1999 in Japan for the treatment of ...
    (Date:12/25/2014)... December 26, 2014 Recently, iFitDress.com, the popular ... women, has announced its new selection of black one-shoulder ... on sale now; they are available at discounted prices, up ... “The promotion will last for three weeks only. You know, ... Those who are interested in our new items can visit ...
    (Date:12/25/2014)... (PRWEB) December 25, 2014 Recently, ... discounts on all its wedding dresses. BellasDress has chosen ... more for gift choices for the holiday season. ... can pick suitable wedding gowns here at discount prices. ... shopping experience at its website. , “All ...
    Breaking Medicine News(10 mins):Health News:Induction Brazing Equipment Series From DaWei Induction Heating Co., A Reliable Supplier Of Induction Heating Equipment 2Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 2Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 3Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:iFitDress.com: Black One-Shoulder Cocktail Dresses for 2015 2Health News:BellasDress.com’s Christmas Sale: Trendy Wedding Dresses With Big Discounts 2
    ... on the human genome project , which is ... the genes will enable one to have the information to ... even skin. It will also help say whether a cell ... in the womb for diseases, and device specific advancements against ...
    ... published in the December issue of the Journal ... in peripheral blood mononuclear cells (PBMCs) from individuals ... infected patients treated with antifilarial agents. According ... the National Institute of Allergy and Infectious Diseases ...
    ... the heart attack patients should get an immediate procedures to ... , ,Cleveland Clinic cardiologist, Dr. Deepak Bhatt analyzed medical ... that patients whose white blood cell count is in what ... risk of death after a heart attack than patients with ...
    ... Lewy body disease, and Multiple System Arophy - ... symptomatic due to a deficiency of a specific ... is dopamine. When the neurons that produce these ... oxidation, the eventual results are tremors and sometimes ...
    ... to diagnose and many a times the diagnosis is ... emerging as a promising technique for early diagnosis of ... facilitating rapid amplification of small amounts of a genome ... Urology Congress in India. Presence of even one ...
    ... ingredient found in many non-prescription cough and cold medications. ... risk of stroke by 23 percent. Dr.Ralph I. Horwitz, ... have linked exposure to PPA to the occurrence of ... results when an artery wall ruptures and prevents blood ...
    Cached Medicine News:
    Designed to give maximum drying area while taking up minimal bench space....
    The Durafuge 100 spins swing-out rotors at 4000 rpm and fixed-angle rotors at up to 6300 rpm....
    Thermostatically controlled, large capacity surface to quickly evaporate water and solvents from slides and mounting media....
    Compact instrument that quickly dries racks of slides using warm air....
    Medicine Products: